TBX3 directly promotes the expression of Inhibitor of DNA binding 1 (ID1), a key regulator of tumor progression, and inhibits E-cadherin expression via the TBX3-ID1-MITF-axis, promoting migration and invasiveness of melanoma cells [91, 92, 104]. Here, ID1 is linked to neoplasm.